ClinicalTrials.Veeva

Menu

Deep Brain Stimulation on Dual-task Gait Performance in PD

N

National Yang Ming Chiao Tung University

Status

Not yet enrolling

Conditions

Parkinson Disease

Treatments

Procedure: Deep brain stimulation with low frequency
Procedure: Deep brain stimulation with high frequency

Study type

Interventional

Funder types

Other

Identifiers

NCT05314322
2022-02-016A

Details and patient eligibility

About

Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease. Motor symptoms include rigidity, bradykinesia, tremor, and postural instability, these motor symptoms can cause gait dysfunction. Non-motor symptoms include depression, dysarthria, cognitive disability, and sleep disturbance. Although these symptoms can be improved through drug treatment, when the course of PD reaches the middle to late stage, it will still face the situation of weakened drug efficacy and the drug side effects increased. When medication can no longer adequately control the motor symptoms of PD, deep brain stimulation (DBS) becomes a powerful option. DBS is a surgical treatment that involves implanting one or more electrodes into specific areas of the brain, which deliver electrical stimulation to regulate or destroy abnormal neural signal patterns in the target area. The effect of DBS has been proven whether it is in improving motor-related symptoms or non-motor-related symptoms, but there are still some areas that have not been compared before and after the surgery, such as: gait variability, executive functions and dual-task walking. In addition, the parameters of electrical stimulation for DBS will also affect the clinical characteristics of patients. Due to the large difference between individual cases, the recommendation of the electrical stimulation frequency still not be established. Therefore, the influence of DBS and its parameters on the symptoms of PD is a topic worthy of discussion. Purposes: (1) To investigate the long-term effects of DBS on the symptoms of PD. (2) To investigate the effects of DBS stimulation frequencies on walking performance and executive function in individuals with PD.

Enrollment

24 estimated patients

Sex

All

Ages

50 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Idiopathic PD
  • Age: 50~80 yrs old
  • Hoehn and Yahr stage ≤ IV after DBS operation
  • Implanted DBS system for at least 6 months
  • MMSE ≥24

Exclusion criteria

  • Other neurological disorders
  • Any major systemic, psychiatric, visual, and musculoskeletal disturbances or other causes of walking inability

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

24 participants in 2 patient groups

High frequency group
Experimental group
Description:
Deep brain stimulation's parameter: Frequency adjusted to 130Hz, with other parameters fixed
Treatment:
Procedure: Deep brain stimulation with high frequency
Low frequency group
Experimental group
Description:
Deep brain stimulation's parameter: Frequency adjusted to 60Hz, with other parameters fixed
Treatment:
Procedure: Deep brain stimulation with low frequency

Trial contacts and locations

1

Loading...

Central trial contact

Yea-Ru Yang, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems